Trxade Group (MEDS)
NASDAQ:MEDS

Trxade Group (MEDS) Financial Statements

148 Followers

Trxade Group Financial Overview

Trxade Group's market cap is currently ―. The company's EPS TTM is $-28.556; its P/E ratio is -0.45; Trxade Group is scheduled to report earnings on July 22, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ 1.72M$ 2.06M$ 2.25M$ 2.25M
Gross Profit-$ -2.31M$ 1.70M$ 1.64M$ 1.56M
EBIT$ -5.75M$ -9.96M$ 901.39K$ -911.39K$ 4.38M
EBITDA$ -5.75M$ -9.25M$ 1.13M-$ 4.43M
Net Income Common Stockholders$ 22.03M$ -11.67M$ -3.53M$ -1.09M$ 4.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.50M$ 151.91K$ 34.03K$ 745.56K$ 1.20M
Total Assets$ 16.74M$ 12.53M$ 21.65M$ 3.74M$ 4.04M
Total Debt$ 201.58K$ 7.10M$ 6.48M$ 211.43K$ 204.06K
Net Debt$ -3.30M$ 6.95M$ 6.45M$ -534.13K$ -995.94K
Total Liabilities$ 3.12M$ 11.99M$ 10.09M$ 5.04M$ 3.38M
Stockholders Equity$ 13.62M$ 542.35K$ 11.56M$ -1.29M$ 655.14K
Cash Flow-
Free Cash Flow$ -10.19M$ -386.35K$ -603.11K-$ -931.53K
Operating Cash Flow$ -10.19M$ -386.35K$ -603.11K$ 328.57K$ -931.53K
Investing Cash Flow$ 27.43M$ -418.74K$ -207.11K$ -51.80K$ 333.20K
Financing Cash Flow$ -13.90M$ 1.84M$ 114.96K$ -725.28K$ 681.26K
Currency in USD

Trxade Group Earnings and Revenue History

Trxade Group Debt to Assets

Trxade Group Cash Flow

Trxade Group Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis